ArticleAlimentary pharmacology & therapeutics2023

Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease-authors' reply.

Ruben J Colman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.